Market News

The S&P/ASX 200 is trading 0.18 per cent higher at 6,785.30. Futures The SPI futures are up 12 points. Best and worst performers The best-performing sector is REITs, up 1.56 per cent. The worst-performing sector is Materials, down 1.09 per cent. The best-performing large cap is Qantas Airways (ASX:QAN), trading 3.13 per cent higher at […]

Chimeric Therapeutics (ASX:CHM), announced that the FDA has cleared the Investigational New Drug application of CHM 2101, Chimeric’s first in class CDH17 CAR T cell therapy for gastrointestinal cancers.  Michael R. Bishop, Professor of Medicine and Director at the University of Chicago commented “I am really excited about the planned Phase 1 clinical trial of

At noon, the S&P/ASX 200 is 0.37 per cent higher at 6,798. The SPI futures are pointing to a rise of 22 points. Asia-Pacific markets were mixed with markets awaiting monetary policy decisions by the Bank of Japan. The Bank of Japan is expected to finish its policy meeting later today Australian time. The key

Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company’s drug candidates, highlighting promising data from the  2023 ESMO Congress. Paul Sanger: I’m Paul Sanger for the Finance News Network, and today we’re talking with Immutep (ASX:IMM), and they have a market cap of $380m. Immutep is a clinical-stage biotech company

Stocks rallied on Monday, with the S&P 500 ending the day out of correction territory, as traders kicked off a big week filled with a Federal Reserve rate decision, jobs report and Apple’s earnings. The Dow Jones Industrial Average gained 511.37 points, or 1.58 per cent, to 32,928.96. The 30-stock index registered its best day

On Monday, the ASX experienced a decline of 0.8 percent at 6772.9 points. This drop below 6800 points marked the first time it had done so this year and is its lowest point since October 2022. The decline was influenced by renewed fears that the conflict between Israel and Hamas could escalate into a regional

Even though the economy is booming and job growth continues, inflation is slowing, leading the US Federal Reserve to refrain from raising interest rates this week. The Fed’s favored PCE inflation reading for September saw a slight increase, but rates are expected to remain unchanged after the two-day meeting early Thursday morning, Sydney time. There’s

In the world of investing, Warren Buffett’s recent buying and selling activity has prompted discussions about his current investment strategy. After a four-month hiatus, Buffett’s Berkshire Hathaway has re-entered the market by acquiring over 4 million shares of Occidental Petroleum in the past week. Filings with the US Securities and Exchange Commission, disclosed last week,

Some analysts considered the unexpected 0.9% increase in Australian retail sales in September as an example of a ‘hot’ statistic, indicating that consumers had reawakened after a winter lull. This impression was reinforced by slight revisions to the July and August figures (now 0.2% from 0.2% and 0.6% from 0.5%, respectively). However, a closer examination

Investors had a strong reaction yesterday to IGO’s (ASX:IGO) quarterly report, driven by concerns about the volatile outlook for lithium. IGO’s shares initially plunged by 11% in early trading, but by 11:30 am, the decline had reduced to just over 4%. This reaction was expected, given warnings from other lithium players like Pilbara Minerals about